How researchers boosted an ALS patient's independence with a box and a balloon

Harvard University engineers have built a wearable "soft robotic" device to help an ALS patient with advanced symptoms eat without an aide.

June 10, 2024 Check out STAT+

Sponsored By

Alex Hogan/STAT STAT+ | Watch: How Harvard researchers boosted an ALS patient's independence with a box and a balloon Harvard University engineers have built a wearable "soft robotic" device to help an ALS patient with advanced symptoms eat without an aide. By Timmy Broderick Millions fewer people may need statins, a new study suggests. But guidelines have yet to agree The American Heart Association revised its risk model for cardiovascular disease, but the guidelines for statin use haven't caught up. By Elizabeth Cooney STAT+ | Moderna says data show its combination Covid-flu vaccine generates a strong immune response The findings suggest Moderna may be on track to bring a combination flu and Covid vaccine to the market, potentially as early as autumn 2025. By Helen Branswell Drug Enforcement Administration STAT+ | The inside story of how Lykos' MDMA research went awry The psychedelics company oversaw a pattern of lapses during its clinical trials, according to former employees who spoke with STAT. By Olivia Goldhill STAT+ | Teladoc has a new CEO, but challenges remain the same The new CEO, Chuck Divita, previously led the commercial markets business at GuideWell, the parent company of health plan Florida Blue. By Mohana Ravindranath STAT+ | Medical device trials still don't enroll enough women, study finds A new study found that the number of women enrolled in high-risk medical device trials did not increase from 2010 to 2020. By Lizzy Lawrence Adobe Opinion: How faith leaders like me can help address America's obesity epidemic New public-private partnerships can learn from the progress faith leaders achieved during the Covid-19 pandemic and reach out to people with obesity. By W. Franklyn Richardson Opinion: Curing rare childhood diseases will falter unless Congress steps up Without immediate action by lawmakers, the priority review voucher program will expire. That would be a tragedy for countless children. By Joe and Courtney Dion

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser